{"id":"https://openalex.org/W1982975095","doi":"https://doi.org/10.1208/s12248-011-9297-2","title":"Pharmacodynamic Model of Sodium\u2013Glucose Transporter 2 (SGLT2) Inhibition: Implications for Quantitative Translational Pharmacology","display_name":"Pharmacodynamic Model of Sodium\u2013Glucose Transporter 2 (SGLT2) Inhibition: Implications for Quantitative Translational Pharmacology","publication_year":2011,"publication_date":"2011-08-25","ids":{"openalex":"https://openalex.org/W1982975095","doi":"https://doi.org/10.1208/s12248-011-9297-2","mag":"1982975095","pmid":"https://pubmed.ncbi.nlm.nih.gov/21870203","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3231856"},"language":"en","primary_location":{"id":"doi:10.1208/s12248-011-9297-2","doi":"https://doi.org/10.1208/s12248-011-9297-2","is_oa":true,"landing_page_url":"https://doi.org/10.1208/s12248-011-9297-2","pdf_url":"https://link.springer.com/content/pdf/10.1208/s12248-011-9297-2.pdf","source":{"id":"https://openalex.org/S74983066","display_name":"The AAPS Journal","issn_l":"1550-7416","issn":["1550-7416"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The AAPS Journal","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1982975095"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://link.springer.com/content/pdf/10.1208/s12248-011-9297-2.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013278963","display_name":"Tristan S. Maurer","orcid":"https://orcid.org/0009-0007-2994-1954","observed_orcids":["https://orcid.org/0009-0007-2994-1954"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Tristan S. Maurer","raw_affiliation_strings":["Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Groton, Connecticut, 06340, USA. tristan.s.maurer@pfizer.com","Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Groton, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Groton, Connecticut, 06340, USA. tristan.s.maurer@pfizer.com","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Groton, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101463079","display_name":"Avijit Ghosh","orcid":"https://orcid.org/0000-0001-7842-7512","observed_orcids":["https://orcid.org/0000-0001-7842-7512","https://orcid.org/0009-0000-5058-2342"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Avijit Ghosh","raw_affiliation_strings":["Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Eastern Point Road, Groton, Connecticut, 06340, USA","Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Groton, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Eastern Point Road, Groton, Connecticut, 06340, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Groton, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086102379","display_name":"Nahor Haddish\u2010Berhane","orcid":"https://orcid.org/0009-0008-3071-8255","observed_orcids":["https://orcid.org/0009-0008-3071-8255"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nahor Haddish-Berhane","raw_affiliation_strings":["Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Eastern Point Road, Groton, Connecticut, 06340, USA","Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Groton, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Eastern Point Road, Groton, Connecticut, 06340, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Groton, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031700129","display_name":"Aarti Sawant\u2010Basak","orcid":"https://orcid.org/0000-0003-3749-5222","observed_orcids":["https://orcid.org/0000-0003-3749-5222"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aarti Sawant-Basak","raw_affiliation_strings":["Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Eastern Point Road, Groton, Connecticut, 06340, USA","Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Groton, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Eastern Point Road, Groton, Connecticut, 06340, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Groton, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069463387","display_name":"Carine Boustany","orcid":"https://orcid.org/0000-0003-1333-2242","observed_orcids":["https://orcid.org/0000-0003-1333-2242"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carine M. Boustany-Kari","raw_affiliation_strings":["Department of Cardiovascular, Metabolic and Endocrine Diseases, Pfizer Inc., Groton, Connecticut, USA","Department of Cardiovascular, Metabolic and Endocrine Diseases, Pfizer Inc., Groton, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular, Metabolic and Endocrine Diseases, Pfizer Inc., Groton, Connecticut, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Department of Cardiovascular, Metabolic and Endocrine Diseases, Pfizer Inc., Groton, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073933860","display_name":"Li She","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Li She","raw_affiliation_strings":["Department of Cardiovascular, Metabolic and Endocrine Diseases, Pfizer Inc., Groton, Connecticut, USA","Department of Cardiovascular, Metabolic and Endocrine Diseases, Pfizer Inc., Groton, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular, Metabolic and Endocrine Diseases, Pfizer Inc., Groton, Connecticut, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Department of Cardiovascular, Metabolic and Endocrine Diseases, Pfizer Inc., Groton, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024856526","display_name":"Michael T. Leininger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael T. Leininger","raw_affiliation_strings":["Department of Cardiovascular, Metabolic and Endocrine Diseases, Pfizer Inc., Groton, Connecticut, USA","Department of Cardiovascular, Metabolic and Endocrine Diseases, Pfizer Inc., Groton, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular, Metabolic and Endocrine Diseases, Pfizer Inc., Groton, Connecticut, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Department of Cardiovascular, Metabolic and Endocrine Diseases, Pfizer Inc., Groton, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101604215","display_name":"Tong Zhu","orcid":"https://orcid.org/0000-0003-4931-656X","observed_orcids":["https://orcid.org/0000-0003-4931-656X"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tong Zhu","raw_affiliation_strings":["Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Eastern Point Road, Groton, Connecticut, 06340, USA","Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Groton, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Eastern Point Road, Groton, Connecticut, 06340, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Groton, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046060870","display_name":"Meera Tugnait","orcid":"https://orcid.org/0000-0002-9005-375X","observed_orcids":["https://orcid.org/0000-0002-9005-375X"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meera Tugnait","raw_affiliation_strings":["Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Eastern Point Road, Groton, Connecticut, 06340, USA","Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Groton, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Eastern Point Road, Groton, Connecticut, 06340, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Groton, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019961292","display_name":"Xin Yang","orcid":"https://orcid.org/0000-0003-1888-3721","observed_orcids":["https://orcid.org/0000-0003-1888-3721"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xin Yang","raw_affiliation_strings":["Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Eastern Point Road, Groton, Connecticut, 06340, USA","Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Groton, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Eastern Point Road, Groton, Connecticut, 06340, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Groton, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063251219","display_name":"Emi Kimoto","orcid":"https://orcid.org/0000-0003-1284-2769","observed_orcids":["https://orcid.org/0000-0003-1284-2769"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emi Kimoto","raw_affiliation_strings":["Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Eastern Point Road, Groton, Connecticut, 06340, USA","Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Groton, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Eastern Point Road, Groton, Connecticut, 06340, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Department of Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer Inc., Groton, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020742620","display_name":"Vincent Mascitti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vincent Mascitti","raw_affiliation_strings":["Department of Medicinal Chemistry, Pfizer Inc., Groton, \nConnecticut, USA","Department of Medicinal Chemistry, Pfizer Inc, Groton, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Pfizer Inc., Groton, \nConnecticut, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Department of Medicinal Chemistry, Pfizer Inc, Groton, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024396022","display_name":"Ralph P. Robinson","orcid":"https://orcid.org/0000-0002-4066-5299","observed_orcids":["https://orcid.org/0000-0002-4066-5299"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ralph P. Robinson","raw_affiliation_strings":["Department of Medicinal Chemistry, Pfizer Inc., Groton, \nConnecticut, USA","Department of Medicinal Chemistry, Pfizer Inc, Groton, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Pfizer Inc., Groton, \nConnecticut, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Department of Medicinal Chemistry, Pfizer Inc, Groton, USA","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5013278963"],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":{"value":5090,"currency":"USD","value_usd":5090},"apc_paid":null,"fwci":2.2369,"has_fulltext":true,"cited_by_count":37,"citation_normalized_percentile":{"value":0.86502281,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"13","issue":"4","first_page":"576","last_page":"584"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9639999866485596},{"id":"https://openalex.org/keywords/dapagliflozin","display_name":"dapagliflozin","score":0.9829999804496765},{"id":"https://openalex.org/keywords/pharmacokinetic-pharmacodynamic-modeling","display_name":"pharmacokinetic-pharmacodynamic modeling","score":0.7950000166893005},{"id":"https://openalex.org/keywords/urinary-glucose-excretion","display_name":"urinary glucose excretion","score":0.9750000238418579},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8949999809265137},{"id":"https://openalex.org/keywords/species-differences","display_name":"species differences","score":0.746999979019165},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.46799999475479126},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"drug discovery","score":0.3019999861717224}],"concepts":[{"id":"https://openalex.org/C2777422806","wikidata":"https://www.wikidata.org/wiki/Q409898","display_name":"Dapagliflozin","level":4,"score":0.9553964138031006},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.6932995915412903},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6282481551170349},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6277477741241455},{"id":"https://openalex.org/C63433958","wikidata":"https://www.wikidata.org/wiki/Q1774688","display_name":"Clinical pharmacology","level":2,"score":0.5672241449356079},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.5250144600868225},{"id":"https://openalex.org/C149011108","wikidata":"https://www.wikidata.org/wiki/Q652985","display_name":"Transporter","level":3,"score":0.5149934887886047},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49381956458091736},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3630355894565582},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.3106216788291931},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2474471926689148},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.1795535683631897},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09565269947052002},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001559","descriptor_name":"Benzhydryl Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005960","descriptor_name":"Glucosides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D005960","descriptor_name":"Glucosides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051297","descriptor_name":"Sodium-Glucose Transporter 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1208/s12248-011-9297-2","doi":"https://doi.org/10.1208/s12248-011-9297-2","is_oa":true,"landing_page_url":"https://doi.org/10.1208/s12248-011-9297-2","pdf_url":"https://link.springer.com/content/pdf/10.1208/s12248-011-9297-2.pdf","source":{"id":"https://openalex.org/S74983066","display_name":"The AAPS Journal","issn_l":"1550-7416","issn":["1550-7416"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The AAPS Journal","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2427991","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3231856","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:21870203","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21870203","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The AAPS journal","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3231856","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3231856/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AAPS J","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1208/s12248-011-9297-2","doi":"https://doi.org/10.1208/s12248-011-9297-2","is_oa":true,"landing_page_url":"https://doi.org/10.1208/s12248-011-9297-2","pdf_url":"https://link.springer.com/content/pdf/10.1208/s12248-011-9297-2.pdf","source":{"id":"https://openalex.org/S74983066","display_name":"The AAPS Journal","issn_l":"1550-7416","issn":["1550-7416"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The AAPS Journal","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1982975095.pdf","grobid_xml":"https://content.openalex.org/works/W1982975095.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W1540520646","https://openalex.org/W1895993106","https://openalex.org/W1974366001","https://openalex.org/W1993653361","https://openalex.org/W1997746154","https://openalex.org/W2020159664","https://openalex.org/W2021192252","https://openalex.org/W2026609170","https://openalex.org/W2027179985","https://openalex.org/W2031426306","https://openalex.org/W2033459829","https://openalex.org/W2033648918","https://openalex.org/W2036227043","https://openalex.org/W2064799851","https://openalex.org/W2066259921","https://openalex.org/W2066928947","https://openalex.org/W2083061846","https://openalex.org/W2103196856","https://openalex.org/W2107049799","https://openalex.org/W2109128239","https://openalex.org/W2110590807","https://openalex.org/W2113943669","https://openalex.org/W2117343153","https://openalex.org/W2120242787","https://openalex.org/W2122077393","https://openalex.org/W2135772015","https://openalex.org/W2144465276","https://openalex.org/W2145216021","https://openalex.org/W2146393360","https://openalex.org/W2149973065","https://openalex.org/W2150855258","https://openalex.org/W2152211669","https://openalex.org/W2166618785","https://openalex.org/W2166808297","https://openalex.org/W2171786511","https://openalex.org/W2270474355","https://openalex.org/W2334768963","https://openalex.org/W2356379002","https://openalex.org/W3122152400","https://openalex.org/W4246288537","https://openalex.org/W4406065843"],"related_works":["https://openalex.org/W4323652497","https://openalex.org/W2739607477","https://openalex.org/W4408993219","https://openalex.org/W4379058401","https://openalex.org/W2031315153","https://openalex.org/W2019360140","https://openalex.org/W2287058651","https://openalex.org/W2519512181","https://openalex.org/W2060530397","https://openalex.org/W4391882930"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}